Institution · Newron Pharmaceuticals (Italy)

Most cited papers from Newron Pharmaceuticals (Italy)

Newron Pharmaceuticals (Italy)

What are the most cited papers from Newron Pharmaceuticals (Italy)?

The most cited paper from Newron Pharmaceuticals (Italy) is "An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus" (Elisabetta Traggiai, Stephan Becker, Kanta Subbarao et al., 2004), with 710 citations. Next come "Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs" (608) and "Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen" (550).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 143 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Elisabetta Traggiai, Stephan Becker, Kanta Subbarao et al. · Nature Medicine Open access	11 Jul 2004	710
2	Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs Claudia Binda, Jin Wang, Leonardo Pisani et al. · Journal of Medicinal Chemistry Open access	4 Oct 2007	608
3	Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen Domenico Maione et al. · Science Open access	Jul 2005	550
4	Reverse vaccinology, a genome-based approach to vaccine development Rino Rappuoli · Vaccine	Mar 2001	496
5	The mechanism of action of MF59 – An innately attractive adjuvant formulation Derek T. O’Hagan, Gary S. Ott, Ennio De Gregorio et al. · Vaccine	Jun 2012	487
6	Pili in Gram-positive pathogens John L. Telford, Michèle A. Barocchi, Immaculada Margarit et al. · Nature Reviews Microbiology Review	16 Jun 2006	455
7	Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine Tristan William Clark, Manish Pareek, Katja Höschler et al. · New England Journal of Medicine Open access	10 Sep 2009	445
8	c‐Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs Markus Stein, Fábio Bagnoli, Robert Halenbeck et al. · Molecular Microbiology	Feb 2002	438
9	Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome Manuel J. Rodríguez‐Ortega, Nathalie Norais, Giuliano Bensi et al. · Nature Biotechnology	15 Jan 2006	438
10	Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes Samuele Calabrό, Marco Tortoli, Barbara C. Baudner et al. · Vaccine	7 Jan 2011	438
11	Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species Claudio Donati, Natalia Luisa Hiller, Hervé Tettelin et al. · Genome biology Open access	Oct 2010	414
12	New adjuvants for human vaccines M. Lamine Mbow, Ennio De Gregorio, Nicholas M. Valiante et al. · Current Opinion in Immunology Review	12 May 2010	413
13	Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis Johan Holst, Diana Martin, Richard Arnold et al. · Vaccine	29 May 2009	411
14	Microbiology in the post-genomic era Duccio Medini, Davide Serruto, Julian Parkhill et al. · Nature Reviews Microbiology Review	13 May 2008	358
15	Meat Intake and Risk of Stomach and Esophageal Adenocarcinoma Within the European Prospective Investigation Into Cancer and Nutrition (EPIC) Carlos Alberto Gonzalez et al. · JNCI Journal of the National Cancer Institute Open access	28 Feb 2006	352
16	Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC–EURGAST) Carlos Alberto Gonzalez et al. · International Journal of Cancer Open access	27 Dec 2005	341
17	The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine Audino Podda · Vaccine	Mar 2001	334
18	Genome Analysis Reveals Pili in Group B Streptococcus Peter E. Lauer, C. Daniela Rinaudo, Marco Soriani et al. · Science	30 Jun 2005	316
19	Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants Mariagrazia Pizza, Marzia Monica Giuliani, Maria Rita Fontana et al. · Vaccine	Mar 2001	308
20	Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile Tika Bdr Thapa, Rosanna Leuzzi, Mah Lee Ng et al. · Journal of Bacteriology Open access	21 Nov 2012	296
21	Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations Rupam Borgohain, József Attila Szász, Paolo Stanzione et al. · Movement Disorders Open access	9 Dec 2013	292
22	The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease Luigi Zecca, Ruggero G. Fariello, Peter Franz Riederer et al. · FEBS Letters Open access	18 Dec 2001	288
23	Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment Ulrich Felix Vogel et al. · The Lancet Infectious Diseases	12 Feb 2013	288
24	CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs Kengo Kitadokoro, Domenico Bordo, G. Galli et al. · The EMBO Journal Open access	15 Jan 2001	279
25	Formation of anion‐selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity Ildikò Szabó, Sandra Brutsche, Francesco Tombola et al. · The EMBO Journal Open access	15 Oct 1999	278
26	Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Marı́a Elena Santolaya, Miguel L. O’Ryan, María Teresa Valenzuela et al. · The Lancet	18 Jan 2012	262
27	Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease Rupam Borgohain, József Attila Szász, Paolo Stanzione et al. · Movement Disorders Open access	10 Jul 2014	235
28	Alum adjuvanticity: Unraveling a century old mystery Ennio De Gregorio, Elaine Tritto, Rino Rappuoli · European Journal of Immunology Open access	24 Jul 2008	234
29	Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells Barbara Capecchi, Jeannette Adu‐Bobie, Federica Di Marcello et al. · Molecular Microbiology Open access	2 Dec 2004	233
30	Safety of MF59™ adjuvant Viola Schultze, Vicente D’Agosto, Andreas Wack et al. · Vaccine	23 Apr 2008	227
31	Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding Roberto Petracca, Fabiana Falugi, G. Galli et al. · Journal of Virology Open access	15 May 2000	224
32	Developing vaccines in the era of genomics: a decade of reverse vaccinology Kate L. Seib, Xiaojuan Zhao, Rino Rappuoli · Clinical Microbiology and Infection Open access	20 Jun 2012	217
33	Different cytokine profile and antigen‐specificity repertoire in Helicobacter pylori‐specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer Mario Milco D’Elios, Marta Manghetti, Fabio Almerigogna et al. · European Journal of Immunology	Jul 1997	211
34	The Key Role of Genomics in Modern Vaccine and Drug Design for Emerging Infectious Diseases Kate L. Seib, Gordon Dougan, Rino Rappuoli · PLoS Genetics Open access	26 Oct 2009	207
35	MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile Audino Podda, Giuseppe Del Giudice · Expert Review of Vaccines	Apr 2003	203
36	Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays Renata Grifantini, Erika Bartolini, Alessandro Muzzi et al. · Nature Biotechnology	12 Aug 2002	203
37	Safinamide Carla Caccia, Roberto Maj, Marco Calabresi et al. · Neurology	10 Oct 2006	196
38	The Fur repressor controls transcription of iron‐activated and ‐repressed genes in Helicobacter pylori Isabel Delany, Gunther Spohn, Rino Rappuoli et al. · Molecular Microbiology Open access	Dec 2001	194
39	Characterization of the Syringomycin Synthetase Gene Cluster Eric Guenzi, G. Galli, Ingeborg Grgurina et al. · Journal of Biological Chemistry Open access	Dec 1998	188
40	Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life Matthew D. Snape, Tom Dawson, Philipp Oster et al. · The Pediatric Infectious Disease Journal	15 Sep 2010	187
41	Endogenous versus exogenous exposure to N -nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study Paula Gabriela Jakszyn et al. · Carcinogenesis Open access	29 Mar 2006	184
42	Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidis Isabel Delany, Rino Rappuoli, Vincenzo Scarlato · Molecular Microbiology	8 Apr 2004	183
43	The Gene Cluster for the Biosynthesis of the Glycopeptide Antibiotic A40926 by Nonomuraea Species Margherita Sosio, Sofia Stinchi, Fabrizio Beltrametti et al. · Chemistry & Biology Open access	Jun 2003	180
44	Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity Jes Dietrich, Claire Swetman Andersen, Rino Rappuoli et al. · The Journal of Immunology Open access	Nov 2006	178
45	Complement C1q Is Dramatically Up-Regulated in Brain Microglia in Response to Transient Global Cerebral Ischemia Martin K.-H. Schäfer, Wilhelm Schwaeble, Claes Post et al. · The Journal of Immunology Open access	May 2000	177
46	Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant Marta Marchetti, Michela Rossi, Valentina Giannelli et al. · Vaccine	1998	175
47	Origin, structure, and activity in vitro and in vivo of dalbavancin Adriano Malabarba, Beth P. Goldstein · Journal of Antimicrobial Chemotherapy	Mar 2005	169
48	Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults Sharon E. Frey, Timo Vesikari, Agnieszka Szymczakiewicz‐Multanowska et al. · Clinical Infectious Diseases Open access	24 Sep 2010	163
49	The Intangible Value of Vaccination Rino Rappuoli, Henry I. Miller, Stanley Falkow · Science	9 Aug 2002	163
50	T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions Marisa Benagiano, Annalisa Azzurri, Alessandra Ciervo et al. · Proceedings of the National Academy of Sciences Open access	9 May 2003	160

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.